Insight into the inhibition effect of acidulated serum albumin on amyloid β-protein fibrillogenesis and cytotoxicity

Langmuir

Volumn 30, Issue 32, 2014, Pages 9789-9796

  Xie, Baolong ^a   Li, Xi ^a   Dong, Xiao Yan ^a,b   Sun, Yan ^a,b  

^a TIANJIN UNIVERSITY   (China)

^b SynBio Research Platform   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CYTOTOXICITY; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES;

ALZHEIMERS DISEASE; BIOLOGICAL ANALYSIS; BOVINE SERUM ALBUMINS; ELECTROSTATIC REPULSION; HYDROPHOBIC INTERACTIONS; MECHANISTIC MODELING; NEGATIVELY CHARGED; TERTIARY STRUCTURES;

PROTEINS;

AMYLOID BETA PROTEIN; BOVINE SERUM ALBUMIN;

ANIMAL; BOVINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; PC12 CELL LINE; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CATTLE; CELL SURVIVAL; PC12 CELLS; RATS; SERUM ALBUMIN, BOVINE;

EID: 84906224657     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la5025197     Document Type: Article

References (57)

1. Selkoe, D. J. Alzheimers disease: genes, proteins, and therapy Physiol. Rev. 2001, 81, 26
2. Vitiello, G.; Di Marino, S.; DUrsi, A. M.; DErrico, G. Omega-3 fatty acids regulate the interaction of the Alzheimers abeta(25-35) peptide with lipid membranes Langmuir 2013, 29, 14239-14245
3. Jakob-Roetne, R.; Jacobsen, H. Alzheimers disease: from pathology to therapeutic approaches Angew. Chem., Int. Ed. 2009, 48, 3030-3059
4. Sehgal, N.; Gupta, A.; Valli, R. K.; Joshi, S. D.; Mills, J. T.; Hamel, E.; Khanna, P.; Jain, S. C.; Thakur, S. S.; Ravindranath, V. Withania somnifera reverses Alzheimers disease pathology by enhancing low-density lipoprotein receptor-related protein in liver Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 6
5. Brambilla, D. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimers disease ACS Nano 2012, 6, 5897-5908
6. Thapa, A.; Vernon, B. C.; De la Pena, K.; Soliz, G.; Moreno, H. A.; Lopez, G. P.; Chi, E. Y. Membrane-mediated neuroprotection by curcumin from amyloid-beta-peptide-induced toxicity Langmuir 2013, 29, 11713-11723
7. Liao, Y. H.; Chang, Y. J.; Yoshiike, Y.; Chang, Y. C.; Chen, Y. R. Negatively charged gold nanoparticles inhibit Alzheimers amyloid-beta fibrillization, induce fibril dissociation, and mitigate neurotoxicity Small 2012, 8, 3631-3639
8. Tanzi, R. E.; Bertram, L. Twenty years of the Alzheimers disease amyloid hypothesis: a genetic perspective Cell 2005, 120, 545-555
9. Richman, M.; Perelman, A.; Gertler, A.; Rahimipour, S. Effective targeting of Abeta to macrophages by sonochemically prepared surface-modified protein microspheres Biomacromolecules 2013, 14, 110-116
10. Jonsson, T.; Atwal, J. K.; Steinberg, S.; Snaedal, J.; Jonsson, P. V.; Bjornsson, S.; Stefansson, H.; Sulem, P.; Gudbjartsson, D.; Maloney, J.; Hoyte, K.; Gustafson, A.; Liu, Y.; Lu, Y.; Bhangale, T.; Graham, R. R.; Huttenlocher, J.; Bjornsdottir, G.; Andreassen, O. A.; Jonsson, E. G.; Palotie, A.; Behrens, T. W.; Magnusson, O. T.; Kong, A.; Thorsteinsdottir, U.; Watts, R. J.; Stefansson, K. A mutation in APP protects against Alzheimers disease and age-related cognitive decline Nature 2012, 488, 96-99
11. Jiang, D.; Rauda, I.; Han, S.; Chen, S.; Zhou, F. Aggregation pathways of the amyloid beta(1-42) peptide depend on its colloidal stability and ordered beta-sheet stacking Langmuir 2012, 28, 12711-12721
12. Zhang, Y. W.; Thompson, R.; Zhang, H.; Xu, H. APP processing in Alzheimers disease Mol. Brain 2011, 4, 3
13. Yu, X.; Wang, Q.; Lin, Y.; Zhao, J.; Zhao, C.; Zheng, J. Structure, orientation, and surface interaction of Alzheimer amyloid-beta peptides on the graphite Langmuir 2012, 28, 6595-6605
14. Stanyon, H. F.; Viles, J. H. Human Serum albumin can regulate amyloid-beta peptide fiber growth in the brain interstitium: implications for Alzheimer disease J. Biol. Chem. 2012, 287, 28163-28168
15. Cramer, P. E.; Cirrito, J. R.; Wesson, D. W.; Lee, C. Y.; Karlo, J. C.; Zinn, A. E.; Casali, B. T.; Restivo, J. L.; Goebel, W. D.; James, M. J.; Brunden, K. R.; Wilson, D. A.; Landreth, G. E. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models Science 2012, 335, 1503-1506
16. Yoo, S. I.; Yang, M.; Brender, J. R.; Subramanian, V.; Sun, K.; Joo, N. E.; Jeong, S. H.; Ramamoorthy, A.; Kotov, N. A. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins Angew. Chem., Int. Ed. 2011, 50, 5110-5115
17. Adessi, C.; Frossard, M. J.; Boissard, C.; Fraga, S.; Bieler, S.; Ruckle, T.; Vilbois, F.; Robinson, S. M.; Mutter, M.; Banks, W. A.; Soto, C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimers disease J. Biol. Chem. 2003, 278, 13905-13911
18. Sciarretta, K. L.; Gordon, D. J.; Meredith, S. C. Peptide-based inhibitors of amyloid assembly Methods Enzymol. 2006, 413, 273-312
19. Palhano, F. L.; Lee, J.; Grimster, N. P.; Kelly, J. W. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils J. Am. Chem. Soc. 2013, 135, 7503-7510
20. Necula, M.; Kayed, R.; Milton, S.; Glabe, C. G. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct J. Biol. Chem. 2007, 282, 10311-10324
21. Chan, H. M.; Xiao, L.; Yeung, K. M.; Ho, S. L.; Zhao, D.; Chan, W. H.; Li, H. W. Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis Biomaterials 2012, 33, 4443-4450
22. Xiao, L.; Zhao, D.; Chan, W. H.; Choi, M. M.; Li, H. W. Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots Biomaterials 2010, 31, 91-98
23. Kerr, M. L.; Gasperini, R.; Gibbs, M. E.; Hou, X.; Shepherd, C. E.; Strickland, D. K.; Foa, L.; Lawen, A.; Small, D. H. Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein J. Neurochem. 2010, 112, 1199-1209
24. Milojevic, J.; Raditsis, A.; Melacini, G. Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism Biophys. J. 2009, 97, 2585-2594
25. Palivan, C. G.; Fischer-Onaca, O.; Delcea, M.; Itel, F.; Meier, W. Protein-polymer nanoreactors for medical applications Chem. Soc. Rev. 2012, 41, 2800-2823
26. Klonoff-Cohen, H.; Barrett-Connor, E. L.; Edelstein, S. L. Albumin levels as a predictor of mortality in the healthy elderly J. Clin. Epidemiol. 1992, 45, 207-212
27. Inhee, C.; Lee, P.; Rapid, L. Detection of Aβ aggregation and inhibition by dual functions of gold nanoplasmic particles: catalytic activator and optical reporter ACS Nano 2013, 7, 10
28. Kuo, Y. M.; Kokjohn, T. A.; Kalback, W.; Luehrs, D.; Galasko, D. R.; Chevallier, N.; Koo, E. H.; Emmerling, M. R.; Roher, A. E. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma Biochem. Biophys. Res. Commun. 2000, 268, 750-756
29. Rozga, M.; Kloniecki, M.; Jablonowska, A.; Dadlez, M.; Bal, W. The binding constant for amyloid Abeta40 peptide interaction with human serum albumin Biochem. Biophys. Res. Commun. 2007, 364, 714-718
30. Elovaara, I.; Palo, J.; Erkinjuntti, T.; Sulkava, R. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimers disease and multi-infarct dementia Eur. J. Neurol. 1987, 26, 229-234
31. Kay, A. D.; May, C.; Papadopoulos, N. M.; Costello, R.; Atack, J. R.; Luxenberg, J. S.; Cutler, N. R.; Rapoport, S. I. CSF and serum concentrations of albumin and IgG in Alzheimers disease Neurobiol. Aging 1987, 8, 21-25
32. Mahmoudi, M.; Quinlan-Pluck, F.; Monopoli, M. P.; Sheibani, S.; Vali, H.; Dawson, K. A.; Lynch, I. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid beta protein fibrillation in solution ACS Chem. Neurosci. 2013, 4, 475-485
33. Kim, S. T.; Saha, K.; Kim, C.; Rotello, V. M. The role of surface functionality in determining nanoparticle cytotoxicity Acc. Chem. Res. 2013, 46, 681-691
34. Santa-María, I.; Hernández, F.; Moreno, F. J.; Avila, J. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-β-peptide aggregation Neurosci. Lett. 2007, 429, 91-94
35. Xu, Y.; Takai, M.; Ishihara, K. Protein adsorption and cell adhesion on cationic, neutral, and anionic 2-methacryloyloxyethyl phosphorylcholine copolymer surfaces Biomaterials 2009, 30, 4930-4938
36. Gu, M.; Kilduff, J. E.; Belfort, G. High throughput atmospheric pressure plasma-induced graft polymerization for identifying protein-resistant surfaces Biomaterials 2012, 33, 1261-1270
37. D.Powers, J. Trypsin purification by affinity binding to small unilamellar liposomes Biotechnol. Bioeng. 1990, 36, 14
38. Bujacz, A. Structures of bovine, equine and leporine serum albumin Acta Crystallogr., Sect. D 2012, 68, 1278-12789
39. Khurana, R.; Coleman, C.; Ionescu-Zanetti, C.; Carter, S. A.; Krishna, V.; Grover, R. K.; Roy, R.; Singh, S. Mechanism of thioflavin T binding to amyloid fibrils J. Struct. Biol. 2005, 151, 229-238
40. Shearman, M. S. Toxicity of protein aggregates in PC12 cells: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay Methods Enzymol. 1999, 309, 716-723
41. Zhang, C.; Wan, X.; Zheng, X.; Shao, X.; Liu, Q.; Zhang, Q.; Qian, Y. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimers disease mice Biomaterials 2014, 35, 456-465
42. Chen, Q.; Yang, L.; Zheng, C.; Zheng, W.; Zhang, J.; Zhou, Y.; Liu, J. Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Abeta-peptide associated with Alzheimers disease Nanoscale 2014, 6, 6886-6897
43. Veloso, A. J.; Kerman, K. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach Bioelectrochemistry 2012, 84, 49-52
44. Giordano, C.; Sansone, A.; Masi, A.; Masci, A.; Mosca, L.; Chiaraluce, R.; Pasquo, A.; Consalvi, V. Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects? Chem. Biol. Drug. Des. 2012, 79, 30-37
45. Zhang, W.; Du, Y.; Bai, M.; Xi, Y.; Li, Z.; Miao, J. S14G-humanin inhibits Abeta1-42 fibril formation, disaggregates preformed fibrils, and protects against Abeta-induced cytotoxicity in vitro J. Pept. Sci. 2013, 19, 159-165
46. Jan, A.; Hartley, D. M.; Lashuel, H. A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimers disease research Nat. Protoc. 2010, 5, 1186-1209
47. Kim, T.; Vidal, G. S.; Djurisic, M.; William, C. M.; Birnbaum, M. E.; Garcia, K. C.; Hyman, B. T.; Shatz, C. J. Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimers model Science 2013, 341, 1399-1404
48. Li, H.; Du, Z.; Lopes, D. H.; Fradinger, E. A.; Wang, C.; Bitan, G. C-terminal tetrapeptides inhibit Abeta42-induced neurotoxicity primarily through specific interaction at the N-terminus of Abeta42 J. Med. Chem. 2011, 54, 8451-8460
49. Monji, A.; Tashiro, K.-i.; Yoshida, I.; Kaname, H.; Hayashi, Y.; Matsuda, K.; Tashiro, N. Laminin inhibits both Aβ40 and Aβ42 fibril formation but does not affect Aβ40 or Aβ42-induced cytotoxicity in PC12 cells Neurosci. Lett. 1999, 266, 85-88
50. Cabaleiro-Lago, C.; Quinlan-Pluck, F.; Lynch, I.; Lindman, S.; Minogue, A. M.; Thulin, E.; Walsh, D. M.; Dawson, K. A.; Linse, S. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles J. Am. Chem. Soc. 2008, 130, 15437-15443
51. Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Dobeli, H.; Schubert, D.; Riek, R. 3D structure of Alzheimers amyloid-beta(1-42) fibrils P. Natl. Acad. Sci. U.S.A. 2005, 102, 17342-17347
52. Pellarin, R.; Caflisch, A. Interpreting the Aggregation Kinetics of Amyloid Peptides J. Mol. Biol. 2006, 360, 882-892
53. Wood, S. J.; Maleeff, B.; Hart, T.; Wetzel, R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimers amyloid peptide Aβ J. Mol. Biol. 1996, 256, 870-877
54. Algamal, M.; Milojevic, J.; Jafari, N.; Zhang, W.; Melacini, G. Mapping the interactions between the Alzheimers Abeta-peptide and human serum albumin beyond domain resolution Biophys. J. 2013, 105, 1700-1709
55. Yang, C.; Li, J. Y.; Li, Y.; Zhu, X. L. The effect of solvents on the conformations of amyloid beta-peptide (1-42) studied by molecular dynamics simulation J. Mol. Struct. 2009, 895, 1-8
56. Zhang, L.; Zhao, G.; Sun, Y. Effects of ligand density on hydrophobic charge induction chromatography: molecular dynamics simulation J. Phys. Chem. B 2010, 114, 2203-2211
57. Zhang, L.; Zhao, G.; Sun, Y. Molecular insight into protein conformational transition in hydrophobic charge induction chromatography: a molecular dynamics simulation J. Phys. Chem. B 2009, 113, 6873-6880